1-5 of 5
Daniel A. Haber
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CN08-02: Molecular detection and characterization of circulating tumor cells

Daniel A. Haber
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): CN08-02.
https://doi.org/10.1158/1535-7163.TARG-17-CN08-02
Published: 01 January 2018
View article titled, Abstract CN08-02: Molecular detection and characterization of circulating tumor cells
Journal Articles

Abstract C137: Rapid assessment of TORC1 suppression as a functional biomarker predicting responsiveness to RAF and MEK inhibitors in BRAF-mutant melanoma patients.

Ryan B. Corcoran, S. Michael Rothenberg, Aaron N. Hata, Anthony C. Faber, Adriano Piris, Rosalynn M. Nazarian, Ronald D. Brown, Jason T. Godfrey, Daniel Winokur, John Walsh, Mari Mino-Kenudson, Shyamala Maheswaran, Jeffrey Settleman, Jennifer A. Wargo, Keith T. Flaherty, Daniel A. Haber, Jeffrey A. Engelman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): C137.
https://doi.org/10.1158/1535-7163.TARG-13-C137
Published: 01 November 2013
View article titled, Abstract C137: Rapid assessment of TORC1 suppression as a functional biomarker predicting responsiveness to RAF and MEK inhibitors in BRAF-mutant melanoma patients.
Journal Articles

Abstract PL06-04: Molecular characterization of circulating tumor cells.

Daniel A. Haber, Shyamala Maheswaran, Lecia Sequist, Min Yu, Emre Ozkumur, David Ting, David Miyamoto, Richard Lee, Ajay Shah, Aditya Bardia, Shannon Stott, Mehmet Toner
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): PL06-04.
https://doi.org/10.1158/1535-7163.TARG-13-PL06-04
Published: 01 November 2013
View article titled, Abstract PL06-04: Molecular characterization of circulating tumor cells.
Journal Articles

Abstract C155: Inhibition of TAK1 promotes apoptosis in KRAS and Wnt pathway codependent colon cancers.

Anurag Singh, Michael F. Sweeney, Jeff Settleman, Daniel A. Haber
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): C155.
https://doi.org/10.1158/1535-7163.TARG-11-C155
Published: 12 November 2011
View article titled, Abstract C155: Inhibition of TAK1 promotes apoptosis in KRAS and Wnt pathway codependent colon cancers.
Journal Articles

The T790M “gatekeeper” mutation in EGFR mediates resistance to low concentrations of an irreversible EGFR inhibitor

Nadia Godin-Heymann, Lindsey Ulkus, Brian W. Brannigan, Ultan McDermott, Jennifer Lamb, Shyamala Maheswaran, Jeffrey Settleman, Daniel A. Haber
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 874–879.
https://doi.org/10.1158/1535-7163.MCT-07-2387
Published: 15 April 2008
View article titled, The T790M “gatekeeper” mutation in <em>EGFR</em> mediates resistance to low concentrations of an irreversible EGFR inhibitor
Open the PDF for The T790M “gatekeeper” mutation in <em>EGFR</em> mediates resistance to low concentrations of an irreversible EGFR inhibitor in another window